GEN Restaurant Group, Inc. (GENK) — the operator of the GEN Korean BBQ casual-dining concept — is a micro-cap with unusually thin sell-side coverage, which makes any "consensus" figure less reliable than it is for large-cap names. The most recent verifiable analyst price target is $2.50 from Roth MKM (George Kelly, Buy), reiterated in May 2026 after being lowered from $3.00 in April 2026. That figure is also the average analyst price target reported by data providers such as TipRanks and Yahoo Finance.
Context matters. A year earlier, Craig-Hallum carried a $4.50 Buy target, but that predates a dramatic decline in the shares and is best treated as stale. In April 2026, Benchmark's Todd Brooks downgraded GENK to Hold from Buy, reflecting caution on near-term fundamentals. The practical range of still-relevant targets is therefore narrow — roughly $2.50 — with meaningful disagreement over the near-term outlook rather than a broad spread of prices. This $2.50 target is a single, recent analyst view rather than a robust multi-analyst average, and it should be read accordingly. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
GENK trades near $1.49–$1.53, with its 52-week range spanning roughly $1.21 to $2.85. From that level, a move to $2.50 implies approximately 68% upside — a very large advance for any stock, and especially ambitious for a company that is currently unprofitable. The stock has lost roughly half its value over the trailing year and trades well below its 2023 IPO-era levels.
A path to $2.50 would likely require a combination of stabilizing restaurant same-store sales, evidence that the company's newer retail/CPG initiatives are scaling profitably, and a return toward positive earnings. Management has pointed to easing year-over-year comparisons and a slate of initiatives aimed at improving results later in 2026, but that trajectory is not yet reflected in reported results.
The clearest positive is strategic diversification. Through 2026, GENK announced distribution agreements with United Natural Foods (UNFI) and C&S Wholesale Grocers, along with retail placements at Costco, Save Mart, Smart & Final, and regional grocers for its marinated-meat products. Management framed these moves as accelerating CPG and multi-channel growth, and appointed a new CFO, Luke A. Hewko, in June 2026 to lead that expansion. If retail distribution converts into meaningful, higher-margin revenue, it could give analysts reason to lift targets. A return to positive same-store sales as comparisons ease would be another key catalyst.
The obstacles are substantial. GENK is loss-making, with negative earnings per share (EPS) on a trailing basis, and its first-quarter 2026 results were characterized by some commentators as a miss. Benchmark's downgrade to Hold signals skepticism that the turnaround is near. The company also carries high leverage relative to its small equity base, and negative free cash flow limits its ability to fund expansion. As a micro-cap with a small public float, the shares are susceptible to sharp, sentiment-driven moves in either direction — volatility that works against a steady climb toward any target.
Technically, GENK remains in a pronounced long-term downtrend. The 52-week high near $2.85 sits above the $2.50 target and represents the most obvious overhead resistance zone, while the 52-week low near $1.21 is the nearest meaningful support. Psychologically, $2.00 and $2.50 are natural round-number hurdles. A sustained move back above $2.00, ideally on rising volume, would be an early technical signal that the downtrend is weakening; failure to hold above roughly $1.20 would suggest continued downside risk. From what I see, the AI Trend Prediction Engine on Tickeron helps flag these shifts in real time.
Analyst price targets typically reflect a roughly 12-month research horizon, though for a thinly covered micro-cap that timeframe is inherently less precise. The most important near-term items are quarterly earnings and same-restaurant sales, plus any signs that the retail/CPG channel is translating distribution wins into revenue and gross-margin improvement. Investors should also watch analyst revisions — an upgrade or target increase from Roth MKM, or a return to a more constructive stance from Benchmark, would be notable — as well as leverage and cash-flow trends and broader consumer-discretionary spending conditions. I’m watching this closely for any updates on the CPG side.
I often turn to Tickeron’s AI Daily Buy/Sell Signals when reviewing names like this one. The platform applies artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as conditions change. For a volatile micro-cap with limited coverage, these systematic signals provide a useful complement to traditional analysis, helping me spot potential shifts without replacing my own judgment.
The $2.50 target is a single recent analyst price target, not a broad consensus, and it sits roughly 68% above the current price — a very large required move for a loss-making micro-cap in a long downtrend. The bull case rests on a credible pivot into retail distribution and eventual stabilization of restaurant sales; the bear case rests on negative earnings, high leverage, and the risk that new initiatives do not scale profitably. Because coverage is so thin, the target carries more uncertainty than typical analyst averages. Investors should monitor quarterly results, same-store sales, retail-channel execution, and any analyst revisions rather than treat $2.50 as a reliable forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GENK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 31 cases where GENK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GENK's RSI Indicator exited the oversold zone, 20 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where GENK advanced for three days, in 122 of 151 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GENK as a result. In 45 of 50 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for GENK turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 34 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GENK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.423) is normal, around the industry mean (-0.877). P/E Ratio (-1.512) is within average values for comparable stocks, (18.791). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (7.754). Dividend Yield (0.094) settles around the average of (0.049) among similar stocks. P/S Ratio (0.040) is also within normal values, averaging (2.618).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. GENK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GENK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Restaurants